Streptomyces carzinostaticus subsp. neocarzinostaticus Ishida et al. 拉丁名
ATCC
15944
編號(hào)
Strain Designations 菌株別名 E-793 F-51 [C-9544-JP9]
Application 用途 Produces zinostatin neocarzinostatin
Biosafety Level 安全等級(jí) 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format 提供形式 freeze-dried
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol

no
Type Strain 模式菌株 no
Medium 培養(yǎng)基 ATCC

Medium 196: Yeast malt extract agar
Growth Conditions 生長(zhǎng)條件
Temperature 培養(yǎng)溫度 : 26.0°C
Name of Depositor 寄存人 Bristol Labs.
U.S. Patent Number
3,334,022
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
References 參考文獻(xiàn)
Ishida N, et al. Neocarzinostatin produced by Streptomyces carzinostaticus var. neocarzinostaticus. US Patent 3,334,022 dated Aug 1 1967
Cross References
Nucleotide (GenBank) : S65575 ncsA=neocarzinostatin apoprotein [Streptomyces carzinostaticus, ssp. neocarzinostaticus E-793, ATCC 15944, Genomic, 751 nt].